boswellic acid has been researched along with imatinib mesylate in 1 studies
| Studies (boswellic acid) | Trials (boswellic acid) | Recent Studies (post-2010) (boswellic acid) | Studies (imatinib mesylate) | Trials (imatinib mesylate) | Recent Studies (post-2010) (imatinib mesylate) |
|---|---|---|---|---|---|
| 227 | 15 | 147 | 11,477 | 960 | 5,773 |
| Protein | Taxonomy | boswellic acid (IC50) | imatinib mesylate (IC50) |
|---|---|---|---|
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 0.31 | |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bordin, L; Brunati, AM; Cillo, U; Gringeri, E; Idotta, G; Magrin, E; Pagano, MA; Tibaldi, E; Zonta, F | 1 |
1 other study(ies) available for boswellic acid and imatinib mesylate
| Article | Year |
|---|---|
The tyrosine phosphatase SHP-1 inhibits proliferation of activated hepatic stellate cells by impairing PDGF receptor signaling.
Topics: Animals; Becaplermin; Benzamides; Cell Membrane; Cell Proliferation; Down-Regulation; Enzyme Activation; Hepatic Stellate Cells; Imatinib Mesylate; Male; Piperazines; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Proto-Oncogene Proteins c-sis; Pyrimidines; Rats; Rats, Wistar; Receptors, Platelet-Derived Growth Factor; Signal Transduction; Triterpenes | 2014 |